Shuyong Zhang

Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy

D. Zheng, Chao Zheng, Shuyong Zhang, 2021, Molecular therapy oncolytics.

A novel humanized anti‐tumor necrosis factor‐related apoptosis‐inducing ligand‐R2 monoclonal antibody induces apoptotic and autophagic cell death

Jiong Cai, D. Zheng, Yan-xin Liu, 2017, IUBMB life.

A novel anti-DR 5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumors

Chao Zheng, Shuyong Zhang, Dongdong Zhou, 2019 .

Therapeutic efficacy of a MMAE-based anti-DR5 drug conjugate Oba01 in preclinical models of pancreatic cancer

J. Liu, D. Zheng, Chao Zheng, 2023, Cell death & disease.

A novel anti-DR5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumors

D. Zheng, Chao Zheng, Shuyong Zhang, 2019, Theranostics.